Regulatory PathRegulatory requirements compared

Active substance

Cortisone

Open in the medicines table

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
CORTONE25MG/ML; 50MG/MLinjectable · injectionMERCKDiscontinued13 Jun 1950
CORTONE25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**tablet · oralMERCKDiscontinued4 Dec 1950
CORTISONE ACETATE25MG; 5MG; 10MGtablet · oralPHARMACIA AND UPJOHNDiscontinued2 Nov 1951
CORTISONE ACETATE25MG/MLinjectable · injectionPHARMACIA AND UPJOHNDiscontinued2 Nov 1951
CORTISONE ACETATE25MG; 5MGtablet · oralPANRAYDiscontinued14 Jan 1952
CORTISONE ACETATE25MGtablet · oralIVAX SUB TEVA PHARMSDiscontinued3 Jan 1972
CORTISONE ACETATE25MGtablet · oralHIKMA INTL PHARMSDiscontinued13 Jun 1972
CORTISONE ACETATE25MGtablet · oralWHITEWORTH TOWN PLSNDiscontinued20 Jun 1973
CORTISONE ACETATE25MGtablet · oralIVAX SUB TEVA PHARMSDiscontinued9 Jul 1973
CORTISONE ACETATE25MGtablet · oralBARRDiscontinued31 Aug 1973
CORTISONE ACETATE25MGtablet · oralCHARTWELL MOLECULARDiscontinued17 Oct 1974
CORTISONE ACETATE25MGtablet · oralEVERYLIFEDiscontinued22 Jan 1975
CORTISONE ACETATE25MG/ML; 50MG/MLinjectable · injectionWATSON LABSDiscontinued7 Mar 1978
CORTISONE ACETATE25MGtablet · oralWATSON LABSDiscontinued15 May 1978
CORTISONE ACETATE25MGtablet · oralIMPAX LABSDiscontinued17 Sep 2001
CORTISONE ACETATE25MGtablet · oralVITARINEDiscontinued
CORTISONE ACETATE25MGtablet · oralPUREPAC PHARMDiscontinued
CORTISONE ACETATE25MGtablet · oralINWOOD LABSDiscontinued
CORTISONE ACETATE25MGtablet · oralELKINS SINNDiscontinued
CORTISONE ACETATE25MG/ML; 50MG/MLinjectable · injectionWATSON LABSDiscontinued
CORTISONE ACETATE25MGtablet · oralHEATHERDiscontinued

Canada Canada — marketed products (Health Canada)

BrandDINStrengthForm · routeCompany
CORTISONE ACETATE0028043725 MGTABLET · ORALBAUSCH HEALTH, CANADA INC.

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.